The global intraosseous infusion devices market size was valued at USD 943.2 million in 2021 and is poised to grow at a significant CAGR of 5.6% during the forecast period 2022-28. Intraosseous (IO) infusion is injecting drugs and fluids directly into the bone's marrow, allowing for quick access to the circulatory system. When intravenous (IV) access is not possible and quick vascular access is required, intraosseous infusion has various advantages. Furthermore, any fluid or drug that can be given through the IV route can also be given through the IO method. When compared to the IV method, the IO route offers the same or quicker rate of drug/fluid administration, and conditions like cardiac arrest, arrhythmias, anaphylactic shock, and other frequent medical problems typically necessitate prompt medical care and medication administration.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/intraosseous-infusion-devices-market/     

Traumatic injuries, cardiovascular disorders, chronic obstructive pulmonary disease, end-stage renal disease, diabetes, urological disorders, obesity, and severe burns are predicted to drive demand for intraosseous infusion kits. The high success rate of intraosseous implants also contributes to the market's expansion. However, the significant danger of compartment syndrome due to the spilling of fluids and medications into soft tissues may limit the market's total growth. Within the projection period, new opportunities are expected to emerge from the implementation of innovations and developments in treatment techniques and processes for easy and timely drug administration, as well as significant government investments.  

The global intraosseous infusion devices market segmentation:
1) By Product Type: FAST1 Device, Dieckmann Modified Needle, BIG Device, EZ-IO Device, Jamshidi Needle, FASTx Device, NIO
2) By Technology: Battery-Powered Driver, Manual IO Needles, Impact Driven Devices
3) By Route of Administration: Distal Femur, Sternum, Distal and Proximal Tibia, Calcaneus, and Head of Humerus
4) By End-User: Hospitals, Emergency Medical Services, Ambulatory Surgical Centers, and Cardiac Care Centers

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=36884                                                                    

Owing to the rising prevalence of bone and joint problems and improved knowledge of newly established treatment approaches, North America leads the intraosseous infusion kits market. Asia-Pacific, on the other hand, is predicted to increase at the fastest rate in the projection period of 2021 to 2028, owing to rising healthcare spending.

The global intraosseous infusion devices market key players PerSys Medical (US) Pyng Medical Corporation. (Canada) Aero Healthcare (US) Vidacare (US) Teleflex (US) implox Pty Ltd. (Australia) PAVmed (US) Biopsybell (Italy) Becton Dickinson Company/Carefusion Inc. (US) Cook Medical Inc. (US)

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747